# GlaxoSmithKline Biologicals SA - Inspection Records

Source: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e

> Inspection records and compliance data for GlaxoSmithKline Biologicals SA in Rixensart, None. Access full analysis and detailed observations.

---

## Details

- Name: GlaxoSmithKline Biologicals SA
- FEI Number: 3002875226
- City: Rixensart
- State: None
- Country Name: Belgium
- Address Line 1: Rue De L'Institut 89
- Zip Code: None

## Related Documents

- [483 - GlaxoSmithKline Biologicals SA - Unknown Date](https://www.keypedia.com/records/483/glaxosmithkline-biologicals-sa/2460b5ec-845d-4add-905f-e53591d5c1f2) — source: FDA, date: Invalid Date
- [FDA Inspection 1304664 - GlaxoSmithKline Biologicals SA - 2026-02-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a737c389-4e6a-4fcc-94cb-27544c5ade52) — source: FDA, date: February 27, 2026
- [FDA Inspection 1215345 - GlaxoSmithKline Biologicals SA - 2023-06-23](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/f7edf2ba-9037-4e72-9ab4-12d46616e90c) — classification: No Action Indicated (NAI), source: FDA, date: June 23, 2023
- [FDA Inspection 1007184 - GlaxoSmithKline Biologicals SA - 2017-01-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/70cb7ce5-0715-4ec4-8b61-c997bb03b824) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 27, 2017
- [FDA Inspection 900625 - GlaxoSmithKline Biologicals SA - 2014-10-02](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/9e518157-9df1-4b38-9fdf-fe6d1dfe4269) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 2, 2014
- [FDA Inspection 818683 - GlaxoSmithKline Biologicals SA - 2012-10-05](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/b6c161d8-1307-454f-8246-b21976212187) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 5, 2012
- [FDA Inspection 672159 - GlaxoSmithKline Biologicals SA - 2010-06-03](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/4295eb06-bce8-47d9-b105-1abe6654554a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 3, 2010

## Related Companies

- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/3a2bb12d-f7e5-4c09-9678-b4bec58553a9)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/37ed59ef-c570-47ec-8477-ca9c766cac29)
- [Fresenius Medical Care, North America](https://www.keypedia.com/companies/fresenius-medical-care-north-america/90cbe724-7310-49e8-983b-b062488d9710)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/1a3cc4bb-fac0-4252-89c5-c4ed77ea95f3)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/0296844d-4369-423c-824a-f7d71344ec07)
- [Zoetis Manufacturing & Research Spain, S.L.](https://www.keypedia.com/companies/zoetis-manufacturing-research-spain-sl/c6438237-5a22-44d1-8ea5-a466eee486b2)
- [Patheon Italia S.p.A](https://www.keypedia.com/companies/patheon-italia-spa/31dc9e92-7b25-4af0-82b4-c57b3efafbcf)
- [B. Braun Medical Inc](https://www.keypedia.com/companies/b-braun-medical-inc/7d193a37-e8a0-4f0f-aeea-f64ccd959191)
- [Fenwal International, Inc.](https://www.keypedia.com/companies/fenwal-international-inc/f7736da8-9a5b-421a-8f73-803b3504d456)
- [Fresenius USA Manufacturing, Inc](https://www.keypedia.com/companies/fresenius-usa-manufacturing-inc/6a1a5f30-4674-4964-a33e-c6401405fba9)

## Related Officers

- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [Strategic Expert at NovoNordisk; Retired from FDA](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)